There's been a lot of talk about using artificial intelligence in drug development over the past year. Now, it’s a lot closer ...
5don MSN
Scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
More than 300 people across academia and industry spilled into an auditorium to attend a BoltzGen seminar on Thursday, Oct.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback